UPDATE: Glaxo to reopen NC plant this weekend after Legionnaires' scare

The bacteria were found in a cooling tower, and nearly half of the plant's employees have been told to stay away until the situation is cleared up. 

By Sy Mukherjee • Aug. 12, 2015

Where biotech is booming: From Boston, to Raleigh, and beyond

Rents in the Boston biohub are up 7.4%, compared with 2014, to $47.40 per square foot.

By Nicole Gray • Aug. 7, 2015

Bayer, Berkeley-based biotech labor union settle 4-year contract

It includes annual raises of at least 3.2%. 

By Nicole Gray • Aug. 5, 2015

Aprecia's Spritam becomes first FDA-approved 3D printed medication

The drug is meant to treat various types of seizures in children and adults with epilepsy. 

By Nicole Gray • Aug. 4, 2015

Hospira's painkiller recall is ballooning—Is Pfizer getting nervous?

Ketorolac tromethamine is a painkiller used during surgery—and is now on the FDA shortage list as Hospira has to recall even more vials of the drug.

By Nicole Gray • July 29, 2015

Sandoz closing three German and Indian factories

Division head Richard Francis has annouced site closures in Gerlingen and Frankfurt, Germany, as well as Turbhe, India by the end of 2016. 

By Nicole Gray • July 27, 2015

Innovation vs. access: The big drug battle in Trans-Pacific Partnership negotiations

The generics industry worries over the intellectual property provisions of the complex trade agreement.

By Nicole Gray • July 17, 2015

Sun Pharma slashing Ranbaxy's contract manufacturing unit

The division head and other executives have been given severance packages.

By Nicole Gray • July 16, 2015

Sandoz closing plant in India

As part of its efforts to streamline operations, Sandoz is closing an API plant in Mumbai. 

By Nicole Gray • July 16, 2015

J&J could reopen closed factory, revive OTC business

In 2010, quality-control problems led J&J to close a PA-based factory where OTC meds were manufactured. It could reopen soon.

By Nicole Gray • July 15, 2015

White House meeting focuses on reducing use of antibiotics

Hospitals, food producers, and others were encouraged to pledge a reduction in their use of antibiotics to combat resistance.

By Nicole Gray • June 3, 2015

Teva to pay record $1.2B settlement in Provigil case

The pharma firm will pay the FTC for moving to stop generic competitors from entering the market for its sleep disorder drug.

By Randy Lilleston • May 29, 2015

Gilead on R&D hiring spree

Now that its new lab is open in Edmonton, Canada, the company wants to hire up to 170 scientists. 

By Nicole Gray • May 29, 2015

AstraZeneca bets big on biotech with large new Swedish plant

With a $285 million investment, the company will create a biotech manufacturing facility in Sweden.

By Nicole Gray • May 19, 2015

Niger meningitis cases triple in 2 weeks amid dearth of vaccines

But doses of the powerful ceftriaxone have helped hold back some cases.

By Nicole Gray • May 18, 2015

A preview of the new lung cancer data Roche will debut at ASCO

At the end of this month, attendees of the major oncology conference will be able to learn more about trials involving the PD-L1 inhibitor MPDL3280A.

By Nicole Gray • May 15, 2015

Light Technology in Bioimaging: How Spectrophotometers Are Revolutionizing the Field of Medicine

New light technology-based bioimaging system will lead to earlier detection and lifesaving treatments.

May 12, 2015

Why tech transfer could be key to growing pharma in Africa

The African Regulatory Network is calling for technology transfer as a way to increase access to medicines in Africa.

By Nicole Gray • April 28, 2015

Research links poor quality medicines and potential global pandemic

Counterfeit drugs are the biggest threat to the global supply chain—but substandard and degraded drugs are also threats.

By Nicole Gray • April 22, 2015

Bayer pumping $100M into new hemophilia-focused Berkeley testing facility

The new facility will be used to test the company's hemophilia A therapies-in-development.

By Nicole Gray • April 17, 2015

Measuring Color Absorption in Biopharmaceuticals: How Spectrophotometers Determine Analyte Concentrations

Spectrophotometry revolutionizes the world of biopharmaceutical research and development.

March 17, 2015

Amgen: The biotech that's getting on the biosimilar R&D bandwagon

When it comes to generics, it's hunt or be hunted. And Amgen plans to have up to five biosimilars on the market by 2019. 

By Nicole Gray • March 9, 2015

Color Consistency in Pharmaceuticals: Using Spectrophotometry for Blending Powders and Plaques

Sponsored by: We use the word "color consistency" a lot when referring to products that depend on this trait for quality assurance. In the pharmaceutical industry, color consistency means a lot more than the final color outcome of a product. Color consistency in pharmaceutical powders and pl...

March 3, 2015

Juno forges ahead with novel cancer therapy, opens manufacturing facility

Juno may just be a startup. But its CAR-T cancer immunotherapy platform is strong enough to give it the confidence to open its own manufacturing facility in Washington state.

By Nicole Gray • Feb. 10, 2015

Why the FDA wants to double inspectors at Indian manufacturing facilities

It's not because of the manufacturing-related issues you might suspect.

By Nicole Gray • Feb. 6, 2015